R. Di Marsico

435 citations
10 papers · 356 indexed · h-index 5

R. Di Marsico

10 papers receiving 349 citations

Peers

R. Di Marsico
Comparison fields: 5 of 47
  • Cancer Research 130
  • Oncology 235
  • Pulmonary and Respiratory Medicine 154
  • Molecular Biology 145
  • Hematology 18
Replace Mónica Botia with:
Mónica Botia Spain
Alfredo Paredes Spain
Yiming Zhao China
Theodore Stewart Gourdin United States
Atsuro Saijo Japan
F. Daniel United Kingdom
Yun-lian Xia China
İbrahim Petekkaya Türkiye
Lorenz Jost Switzerland
Adam Diehl United States
R. Di Marsico relative to Mónica Botia Spain Mónica Botia's profile →
Citations per field
00.5×
Mónica Botia · 1×
Citations per year

Countries citing papers authored by R. Di Marsico

Since Specialization
Citations

This map shows the geographic impact of R. Di Marsico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Di Marsico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Di Marsico more than expected).

Fields of papers citing papers by R. Di Marsico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Di Marsico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Di Marsico. The network helps show where R. Di Marsico may publish in the future.

Co-authorship network

The 25 scholars most cited alongside R. Di Marsico, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Di Marsico Line = papers co-authored together R. Di Marsico links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 201288
2 20104
3 200971
4 20088
5 2008170
6 20074
7
Low-dose metronomic cyclophosphamide plus celecoxib and dexamethasone in advanced hormone refractory prostate cancer (HRPC): a phase II clinical trial with evaluation of clinical, biologic and pharmacodynamic effects of the combination
20061
8 20054
9 20041
10 20005

About R. Di Marsico

R. Di Marsico is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 10 papers that have together received 356 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Prostate Cancer Treatment and Research (3 papers), Lung Cancer Research Studies (3 papers), Estrogen and related hormone effects (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Cancer Research (130 citations), Oncology (235 citations) and Pulmonary and Respiratory Medicine (154 citations). R. Di Marsico has collaborated with scholars based in Italy, Switzerland and Netherlands. Frequent co-authors include Alfredo Falcone, Andrea Antonuzzo, Romano Danesi, Mario Del Tacca, Enrico Vasile, Carmelo Tibaldi, Cinzia Orlandini, Godefridus J. Peters, Elisa Giovannetti and S Ricciardi. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026